A large-scale genetic analysis has uncovered three distinct biological pathways linking Cannabis Use Disorder (CUD) to psychosis, along with over 500 genetic markers — including 122 newly identified — that may help predict who is most vulnerable to cannabis-related psychotic disorders. The study, published in Biological Psychiatry Global Open Science by researchers at King’s College London’s Institute of Psychiatry, Psychology & Neuroscience, clarifies the molecular underpinnings of a long-observed connection and opens the door to precision risk assessment and tailored interventions.
What the Research Found
Using meta-analysis of genome-wide association studies for both schizophrenia and bipolar 1 disorder — together forming a broad “psychosis clinical group” — the team analyzed genetic data from thousands of participants. They found over 500 genetic loci associated with psychosis, 122 of which were new. Critically, they identified three distinct groups of genetic variants that mediate the causal path from CUD to psychosis. These genes are involved in:
- Neurodevelopment — processes that shape brain structure and function during development.
- Neuronal signaling — how nerve cells communicate, particularly through the glutamate system directly affected by THC.
- Other biological processes — a third group with varied functions.
The study confirms a bidirectional causal link between psychosis and cannabis use, but emphasizes that the strength of the link is significantly greater from CUD to psychosis than the reverse. Notably, only one set of genetic variants was found driving the path from psychosis to heavy cannabis use, mirroring clinical observations of less variability in that direction.
“As conversations around cannabis use increasingly turn to whether it should be legalised, there is an ever increasing need to improve how we identify those at greatest risk from heavy use, as well as to develop tailored interventions for those who have experienced psychosis in the context of cannabis use,” said Professor Marta Di Forti, senior author of the study.
Why It Matters for Your Brain
Understanding these genetic pathways means that one day, a simple genetic test could estimate your personal risk of developing psychosis if you use cannabis heavily. The glutamate system — which THC directly hits — appears to be a key player, suggesting that interventions targeting glutamate could be protective. For brain training enthusiasts, this underscores the link between genetics, environment, and cognition. While not every cannabis user will develop psychosis, knowing your genetic susceptibility could inform safer choices.
What You Can Do
Stay informed about your own cognitive health: monitor how substances affect your thinking and mood, and discuss any family history of psychosis with a healthcare professional. Evidence-based brain training — such as exercises that challenge memory, attention, and reasoning — may support cognitive resilience, but no program can override genetic risk. The best approach is a combination of knowledge, moderation, and lifestyle factors like sleep and stress management.
Source: Neuroscience News
Curious about your own brain? Take our free adaptive IQ test or try 306 brain training levels.
